Venus Medtech (Hangzhou) Inc. announced that the Venus Global Heart Valve Innovation Center will be established in Israel and Mr. Amir Gross will be appointed as the head of the Venus Global Heart Valve Innovation Center. Mr. Amir Gross is the chief executive officer of Cardiovavlve Ltd. (Cardiovavlve), a pioneering transcatheter mitral and tricuspid valve treatment company, which was 100% acquired by the Company in January 2022.